Antileishmanial drugs cause up-regulation of interferon-gamma receptor 1, not only in the monocytes of visceral leishmaniasis cases but also in cultured THP1 cells

Annals of Tropical Medicine and Parasitology

Volumn 97, Issue 3, 2003, Pages 245-257

  Dasgupta, B ^a,d   Roychoudhury, K ^a   Ganguly, S ^b   Kumar Sinha, P ^c   Vimal, S ^c   Das, P ^b   Roy, S ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^c RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTILEISHMANIAL AGENT; ANTIMONY GLUCONATE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; PENTAMIDINE;

ADOLESCENT; ADULT; ARTICLE; CELL LINE; CELL STRAIN THP1; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEISHMANIA; LEISHMANIA DONOVANI; MACROPHAGE; MALE; MONOCYTE; NORTHERN BLOTTING; VISCERAL LEISHMANIASIS;

ACUTE DISEASE; ADOLESCENT; ADULT; ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; BLOTTING, NORTHERN; CELL LINE; CHILD; FEMALE; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MONOCYTES; PENTAMIDINE; RECEPTORS, INTERFERON; UP-REGULATION;

LEISHMANIA DONOVANI; PROTOZOA;

EID: 0038485685     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349803235001714     Document Type: Article

References (46)

1. Anderson, P., Yip, Y. K. & Vilcek, J. (1983). Human interferon-gamma is internalised and degraded by cultured fibroblasts. Journal of Biological Chemistry, 258, 6497-6502.
2. Auwerx, J. (1991). The human leukemia cell line THP1: a multifaceted model for the study of monocyte-macrophage differentiation. Experientia, 47, 22-31.
3. Badaro, R., Falcoff, E., Badaro, F. S., Carvalho, E. M., Pedral-Sampaio, D., Barral, A., Carvalho, J. S., Barral-Netto, M., Brandely, M., Silva, L., Bina, J. C., Teixeira, R., Falcoff, R., Rocha, H., Ho, J. L. & Johnson, W. D. (1990). Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. New England Journal of Medicine, 322, 16-21.
4. Baer, H. P., Schmidt, K., Mayer, B. & Kukovetz, W. R. (1995). Pentamidine does not interfere with nitrite formation in activated RAW 264.7 macrophages but inhibits constitutive brain nitric oxide synthase. Life Sciences, 57, 1973-1980.
5. Bell, C. A., Cory, M., Fairley, T. A., Hall, J. E. & Tidwel, R. R. (1991). Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity. Antimicrobial Agents and Chemotherapy, 35, 1099-1107.
6. Bemabei, P., Allione, A., Rigamonti, L., Bosticardo, M., Losana, G., Borghi, I., Forni, G. & Novelli, F. (2001). Regulation of interferon-gamma receptor (INF-gammaR) chains: a peculiar way to rule the life and death of human lymphocytes. European Cytokine Network, 12, 6-14.
7. Berman, J. D. & Wyler, D. J. (1980). An in vitro model for investigation of chemotherapeutic agents in Leishmania. Journal of Infectious Diseases, 142, 83.
8. Berman, J. D., Edwards, N. & King, M. (1989). Biochemistry of Pentostam resistant Leishmania. American Journal of Tropical Medicine and Hygiene, 40, 159-164.
9. Bitonti, A. J., Dumant, J. A. & McCann, P. P. (1986). Characterization of Trypanosoma brucei brucei S-adenosyl L-methionine decarboxylase and its inhibition by berenil, pentamidine and methylglyoxal bis (Guanylhydrazone). Biochemical Journal, 237, 685-689.
10. Buates, S. & Matlashewski, G. (2001). General suppression of macrophage gene expression during Leishmania donovani infection. Journal of Immunology, 166, 3416-3422.
11. Carrera, L., Gazzinelli, R. T., Badolato, R., Hiney, S., Muller, W., Kuhu, R. & Sacks, D. L. (1996). Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. Journal of Experimental Medicine, 183, 515-526.
12. Carter, N. S. & Fairlamb, A. H. (1993). Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature, 361, 173-176.
13. Celada, A. (1988). The interferon gamma receptor. Lymphokine Research, 7, 61-73.
14. Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162, 156-159.
15. Croft, S. L. (2001) Monitoring drug resistance in leishmaniasis. Tropical Medicine and International Health, 6, 899-905.
16. Dellacasagrande, T., Capo, C., Raoult, D. & Mege, J. L. (1999). IFN-γ mediated control of Coxiella burnetti survival in monocytes: the role of cell apoptosis and TNF. Journal of Immunology, 162, 2259-2265.
17. Delmas, F., di Giorgio, C., Elias, R., Gasquet, M., Azas, N., Mshvildadze, V., Dekanosidze, G., Kemertelidze, E. & Timon-David, P. (2000). Antileishmanial activity of three saponins isolated from ivy, alpha-hederin and hederacolchiside A1, as compared to their action on mammalian cells cultured in vitro. Planta Medica, 66, 343-347.
18. Ebensperger, C., Rhee, S., Muthumaran, G., Lembo, D., Donnelly, R., Pestka, S. & Dembic, Z. (1996). Genomic organization and promoter analysis of the gene ifngr2 encoding the second chain of the mouse interferon-γ receptor. Scandinavian Journal of Immunology, 44, 599-606.
19. Farrar, M. A., Fernandez-Luna, J. & Schreiber, R. D. (1999). Identification of two regions within the cytoplasmic domain of the human interferon-gamma receptor required for function. Journal of Biological Chemistry, 266, 19,626-19,635.
20. Garcia, R. C., Banfi, E. & Pittis, M. G. (2000). Infection of macrophage-like THP1 cells with Mycobacterium avium results in a decrease in their ability to phosphorylate nucleolin. Infection and Immunity, 68, 3121-3128.
21. Gebre-Hiwot, A., Tadesse, G., Croft, S. L. & Frommel, D. (1992). An in vitro model for screening antileishmanial drugs: the human leukemia cell line, THP1. Acta Tropica, 51, 237-245.
22. Goodwin, J. G. & Page, J. E. (1943). Study of the excretion of organic antimonials using a polarographic procedure. Biochemical Journal, 37, 198.
23. Hokertz, S., Baccrani, M. & Lohmann-Mathes, M. L. (1989). Functional heterogeneity of macrophage precursor cells from spleen of Leishmania donovani infected and uninfected mice. Journal of Immunology, 128, 2487-2494.
24. Jha, T. K., Sundar, S., Thakur, C. P., Bachmann, P., Karbwang, J., Fischer, C., Voss, A. & Berman, J. (1999). Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. New England Journal of Medicine, 341, 1795-1800.
25. Luo, Z. D., Wang, Y., Werlen, G., Camp, S., Chien, K. R. & Taylor, P. (1999). Calcineurin enhances acetylcholine esterase mRNA stability during C2-C12 muscle cell differentiation. Molecular Pharmacology, 56, 886-894.
26. Maniatis, T., Fritsch, E. F. & Sambrook, J. (1989). Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Publications.
27. Merlin, G., van der Leede, B.-J., Aguet, M. & Dembic, Z. (1989). The human interferon gamma receptor gene. Journal of Interferon Research, 9, 89.
28. Mohamed, A. M., Taye, T. & Akuffo, H. O. (1992). Mechanisms of resistance to Leishmania aethiopica. Interferon-gamma in combination with a cytokine (not tumor necrosis factor alpha) is required, but cannot act alone in the inhibition of intracellular forms of L. aethiopica in THP1 cells. European Journal of Immunology, 22, 2331-2337.
29. Oliver, M., Baimbridge, K. G. & Reiner, N. E. (1992). Stimulus-response coupling in monocytes infected with Leishmania: attenuation of calcium transients is related to defective agonist-induced accumulation of inositol phosphates. Journal of Immunology, 148, 1188-1196.
30. Pfizenmaier, K., Wiegmann, K., Scheurich, P., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J., Zinkernagel, R. M. & Aguet, M. (1988). High affinity human IFN-gamma-binding capacity is encoded by a single receptor gene located in proximity to c-ras on human chromosome region 6q16 to 6q22. Journal of Immunology, 141, 856-860.
31. Ray, M., Gam, A. A., Boykins, R. A. & Kenny, R. T. (2000). Inhibition of interferon γ signalling by Leishmania donovani. Journal of Infectious Diseases, 181, 1121-1128.
32. Roberts, W. L., Berman, J. D. & Rainey, P. M. (1995). In vitro antileishmanial properties of tri- and pentavalent antimonial preparations. Antimicrobial Agents and Chemotherapy, 39, 1234-1239.
33. Saha, A. K., Mukherjee, T. & Bhaduri, A. (1986). Mechanism of activation of amphotericin B on Leishmania donovani promastigotes. Molecular Biochemistry and Parasitology, 19, 195-200.
34. Saha, B., Roy, H. N., Pakrashi, A., Chakraborti, R. N. & Roy, S. (1991). Immunobiological studies on experimental visceral leishmaniasis. I. Changes in lymphoid organs and their possible role in pathogenesis. European Journal of Immunology, 21, 577-581.
35. Saha, B., Bandopadhyay, D. & Roy, S. (1995). Immunobiological studies on experimental visceral leishmaniasis. IV. Kinetics of evolution of disease promoting versus host protective cells of monocyte-macrophage lineage and their characterization. Scandinavian Journal of Immunology, 42, 540-546.
36. Sands, M., Kron, M. A. & Brown, R. B. (1985). Pentamidine: a review. Reviews of Infectious Diseases, 7, 625-634.
37. Sereno, D., Holzmuller, P. & Lemesre, J. L. (2000). Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum. Acta Tropica, 74, 25-31.
38. Sereno, D., Holzmuller, P., Mangot, I., Cuny, G., Ovaissi, A. & Lemesre, J. L. (2001). Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes. Antimicrobial Agents and Chemotherapy, 45, 2064-2069.
39. Squires, K. E., Rosenkaimer, F., Sherwood, J. A., Forni, A. L., Were, J. B. & Murray, H. W. (1993). Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma. American Journal of Tropical Medicine and Hygiene, 48, 666-669.
40. Sunder, S. (2001). Drug resistance in Indian visceral leishmaniasis. Tropical Medicine and International Health, 6, 849-854.
41. Sundar, S. & Murray, H. W. (1996). Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex. Journal of Infectious Diseases, 173, 762-765.
42. Sundar, S., Rosenkaimer, F. & Murray, H. W. (1994). Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon gamma. Journal of Infectious Diseases, 170, 659-662.
43. Suschek, C. V., Bonmann, E., Kleinert, H. (2000). Amphotericin B severely affects expression and activity of the endothelial constitutive nitric oxide synthase involving altered mRNA stability. British Journal of Pharmacology, 131, 473-481.
44. Taylor, A. P. & Murray, H. W. (1998). Therapeutic effect of interferon-gamma gene transfer in experimental visceral leishmaniasis. Journal of Infectious Diseases, 178, 908-911.
45. Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T. & Tada, K. (1980). Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). International Journal of Cancer, 26, 171-176.
46. World Health Organization (2000). Leishmaniasis and Leishmania/HIV Co-infection. Document WHO/CDS/CSR/ISR/2000.1. Geneva: WHO.